How to Buy Cormedix Stock
Cormedix Inc
CorMedix Inc. , a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally.
Cormedix stock last closed at $11.35, up 0.62% from the previous day, and has increased 163.95% in one year. It has overperformed other stocks in the Biotechnology industry by 2.35 percentage points. Cormedix stock is currently +214.4% from its 52-week low of $3.61, and -34.88% from its 52-week high of $17.43.
At the moment, there are 67.82M shares of CRMD outstanding. The market cap of CRMD is $769.81M. In the past 24 hours, 1.13M CRMD shares were traded.
How to Buy Cormedix Stock
Wondering how to invest in Cormedix stock? Here's how.
- Choose where to buy Cormedix stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Cormedix stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Pick your payment method and add your information.
- Evaluate Cormedix stock: The Cormedix ticker symbol is CRMD. Is Cormedix stock a good investment? Should you buy shares of CRMD? How do CRMD's underlying business fundamentals look? Do top analysts think Cormedix is a good buy? Why has CRMD's stock price moved recently? (Hint: Our stock research website can help you evaluate if CRMD is a good stock to buy).
- Place your CRMD purchase: Decide if you will purchase CRMD shares at the current market price or use a limit order to buy CRMD stock at a specific price.
- Get updates on your CRMD investment: Create a watchlist to monitor your investment in Cormedix shares.
Step 1: Choose where to buy Cormedix stock
You need a brokerage account to access the NASDAQ market and buy CRMD stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal details so you are able to invest in CRMD today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open a new brokerage account.
- Submit your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've created your account on the best stock app for beginners, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details depositing funds into your brokerage account.
Step 4: Evaluate Cormedix stock
Once you have identified the best place to buy Cormedix stock, it's critical to research their stock prior to buying, so you truly understand the risk as well as the opportunity.
Cormedix stock data
CRMD Due Diligence Score
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on CRMD's stock page.
What is the fair value of CRMD stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge CRMD's true value.
Using relative valuations measures:
- CRMD may be undervalued based on its P/E ratio of 43.65x, relative to Biotechnology industry P/E ratio of -151.89x
- CRMD could be overvalued based on its P/B ratio of 6.7x, relative to Biotechnology industry P/B ratio of 4.66x
- CRMD could be undervalued based on its PEG ratio of 0.41x
You can access additional valuation research on CRMD's stock here.
CRMD Financial Health Summary
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the CRMD balance sheet.
- CRMD has $77.50M in cash and short term investments. This is sufficient to cover its annual cash burn of $13.63M.
- CRMD has cash burn of 13632457. It has sufficient cash and short-term investments to cover this for at least one year.
- CRMD has a low debt to equity ratio of 0.3.
- There are more short-term assets than short-term liabilities on the CRMD balance sheet.
Negative Financial Indicators:
- Total CRMD debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy CRMD stock, according to Wall Street analysts?
Out of 6 Wall Street analysts who give forecasts on CRMD, the consensus analyst rating on CRMD is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest CRMD Analyst Ratings
Roanna Ruiz, a bottom 4% analyst from Leerink Partners initiates coverage on CRMD with a buy rating and announces their CRMD price target of $18.00, on Mar 7, 2025.
You can dive deeper into what analysts are projecting on the Cormedix stock forecast page.
CRMD Technicals
CRMD Performance Numbers
Last year, CRMD revenue was $82.55M. During the past five year, CRMD's revenue has gone up by 235.7% per year. This was faster than the Biotechnology industry average of 43.87%.
Find out more about CRMD's earnings and revenue performance here.
Who is buying/selling CRMD?
Over the last year, insiders at CRMD have sold more shares than they have bought.
Steven W. Lefkowitz, Director of CRMD, was the latest CRMD insider to buy. They bought $80,600.00 worth of CRMD shares on Apr 2, 2025.
Research more about who owns CRMD shares here.
Can I rely on CRMD as an income stream?
No, Cormedix doesn't provide an income stream by paying out dividends.
What do other investors have to say about CRMD?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your CRMD purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, place a limit order.
Press the Open Trade button and your broker will execute your order.
If you require more help buying stocks on eToro, click the how to video below:
Step 6: Get updates on your CRMD investment
Now that you own some shares in CRMD, you'll want to keep up with your new stock purchase.
Make a watchlist to get alerted to the latest events about your CRMD stock.
CRMD Feed
How to Buy Stock in Cormedix
To summarize, here are the 6 steps you need to take to buy Cormedix stock right now:
- Choose where to buy Cormedix stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Evaluate Cormedix stock
- Place your CRMD purchase
- Get updates on your CRMD investment
If you are looking for a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Cormedix, hit the button below to create your watchlist.
Other Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.